Stroke Trial, Recruiting NCT06965673 Sponsor: IRCCS San Camillo, Venezia, Italy Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06965673
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are alert and conscious at the time of the study
  • People who have had their first stroke in a single area of the brain, whether caused by a blocked blood vessel or bleeding
  • People whose brain MRI shows no more than two small, silent lesions (areas of damage with no noticeable symptoms), each smaller than 15mm
  • People who have clear symptoms affecting their vision, attention, memory, movement, or language that are confirmed by brain imaging

Who may not be able to join:

  • People who have had a previous stroke that is visible on brain imaging
  • People who have deficits or damage affecting more than one area of the brain at the same time
  • People who are unable to stay alert and focused for the required tests and assessments
  • People with claustrophobia (fear of enclosed spaces) or metal objects in or on their body that would prevent an MRI scan from being performed safely
  • People who have other neurological (brain or nerve), psychiatric (mental health), or general medical conditions that could affect the interpretation of test results or brain imaging

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marco Zorzi, San Camillo IRCCS, Venice, Italy

Phone: +39 049 827 6618

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
IRCCS San Camillo, Venezia, Italy
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
1 June 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change pre-post rehabilitation in eye movements patterns during free viewing; Change pre-post rehabilitation in Behavioral Inattention Test score; Change pre-post rehabilitation in Trail Making Test score; Change pre-post rehabilitation in Posner Test reaction times; Change pre-post rehabilitation in Attention Matrices Test; Change pre-post rehabilitation in Brief Visuospatial Memory Test Revised; Change pre-post rehabilitation in Bells Test; Change pre-post rehabilitation in Apple Test score; Change pre-post rehabilitation in Comb and Razor Test; Change pre-post rehabilitation in Mental Numbe...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov